Document Detail


Comparison of dose frequency of human growth hormone in treatment of organic and idiopathic hypopituitarism.
MedLine Citation:
PMID:  3794876     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two weekly (biw) injections of pituitary human growth hormone (hGH) were compared with three weekly (tiw) injections of hGH (0.24 IU hGH/kg body weight/wk for both groups) for effect on growth rate in children with idiopathic and organic hypopituitarism. Both dosage schedules resulted in increased growth rate during the first 12 months of therapy; the tiw dosage was more effective in the first 6 months in patients with organic hypopituitarism, and in the second 6 months in patients with idiopathic hypopituitarism. There was no advantage to tiw therapy during the second year of therapy in either group. The additional increment in height after 1 year of therapy using tiw compared with biw therapy was 2 cm and 1 cm for the patients with organic and idiopathic hypopituitarism, respectively. This increment should be weighed against the cost, pain, and inconvenience of tiw versus biw doses of hGH in the treatment of hGH deficiency. With the dosages used in this study, tiw therapy was more effective during the first year, when patients are more responsive, and should be recommended. Twice weekly therapy could be considered for the second and possibly subsequent years of therapy. Other schedules of treatment may be more effective than either of these schedules.
Authors:
W V Moore; S Kaplan; S Raiti
Related Documents :
8989226 - Sandostatin lar in acromegalic patients: long-term treatment.
12903796 - Hyponatremia after transspheniodal surgery of pituitary adenoma.
1350936 - Disappearance of a pituitary tumor after 15 months of treatment with cv 205-502, a new ...
11303656 - Acromegaly in the developing world--a 20-year teaching hospital experience.
20466216 - Validity of serum tau protein levels in pediatric patients with minor head trauma.
20952606 - Comparison between standard and high-flexion posterior-stabilized rotating-platform mob...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  The Journal of pediatrics     Volume:  110     ISSN:  0022-3476     ISO Abbreviation:  J. Pediatr.     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-02-05     Completed Date:  1987-02-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375410     Medline TA:  J Pediatr     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  144-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Child
Drug Administration Schedule
Female
Growth / drug effects
Growth Disorders / drug therapy*
Growth Hormone / administration & dosage*,  therapeutic use
Humans
Hypopituitarism / drug therapy*
Male
Chemical
Reg. No./Substance:
9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism rece...
Next Document:  Syndrome of periodic fever, pharyngitis, and aphthous stomatitis.